Literature DB >> 12456321

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Arie Perry1, Christine E Fuller, Ruma Banerjee, Daniel J Brat, Bernd W Scheithauer.   

Abstract

Deletions of chromosomes 1p and 19q are associated with chemosensitivity and enhanced survival in oligodendrogliomas. Therefore, we have utilized FISH analysis as an ancillary tool for diffuse gliomas with suspected oligodendroglial features. To date, 246 gliomas have been analyzed in 131 male and 93 female patients, including 109 oligodendrogliomas (O), 109 mixed oligoastrocytomas/equivocal gliomas (MOA), and 28 astrocytomas (A). To address specificity, we also analyzed 41 oligodendroglioma mimics, including 12 central and 12 extraventricular neurocytomas (EVN), 12 dysembryoplastic neuroepithelial tumors, and 5 clear cell ependymomas. Aside from 2 EVNs, no mimics demonstrated codeletion. Three patterns were associated with glioma cell type (O vs. MOA/A): -1p/19q, -19q alone, and polysomies. Long-term survivals of >5-years (N=47) and >10-years (N=16) were associated with 1p/19q codeletion in 60% and 75% respectively, whereas solitary 19q deletion accounted for 11% and 6% respectively. Survivals<2-years (N=10) were associated with lack of deletions in 70%. A few older patients with high-grade, "genetically favorable" tumors did poorly, whereas prolonged survival was observed in several low-grade glioma patients despite a lack of the "genetically favorable" pattern. Our data suggests that: 1) FISH-detectable 1p/19q codeletion is relatively specific for oligodendrogliomas with long survival, 2) solitary 19q deletion may also portend a favorable prognosis in a smaller subset, and 3) combined clinicopathologic and genetic assessment likely provides a more accurate means of patient stratification than either one alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12456321     DOI: 10.2741/896

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  30 in total

1.  Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Elena Clerici; Anna Maria Ascolese; Matteo Simonelli; Matteo Perrino; Marco Riva; Marco Rossi; Roberta Rudà; Armando Santoro; Lorenzo Bello; Marta Scorsetti
Journal:  CNS Oncol       Date:  2017-07-18

Review 2.  Management of newly diagnosed glioblastoma: guidelines development, value and application.

Authors:  Jeffrey J Olson; Camilo E Fadul; Daniel J Brat; Srinivasan Mukundan; Timothy C Ryken
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

3.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

4.  C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology.

Authors:  Xianfeng F Zhao; Anjum Hassan; Arie Perry; Yi Ning; Sanford A Stass; Louis P Dehner
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

6.  Oligodendroglioma cell lines containing t(1;19)(q10;p10).

Authors:  John J P Kelly; Michael D Blough; Owen D M Stechishin; Jennifer A W Chan; Desiree Beauchamp; Marco Perizzolo; Doug J Demetrick; Lisa Steele; Roland N Auer; Walter J Hader; Morgan Westgate; Ian F Parney; Robert Jenkins; J Gregory Cairncross; Samuel Weiss
Journal:  Neuro Oncol       Date:  2010-04-13       Impact factor: 12.300

7.  CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.

Authors:  Gerald F Reis; Melike Pekmezci; Helen M Hansen; Terri Rice; Roxanne E Marshall; Annette M Molinaro; Joanna J Phillips; Hannes Vogel; John K Wiencke; Margaret R Wrensch; Kyle M Walsh; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2015-05       Impact factor: 3.685

8.  Atypical extraventricular neurocytoma.

Authors:  Hyunho Choi; Sung-Hye Park; Dong Gyu Kim; Sun Ha Paek
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

9.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

10.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.